Clinical Experience of Mesenteric Vascular Diseases and Management.
- Author:
Jae Yool JANG
1
;
Yu Jin KWON
;
Tae Seung LEE
Author Information
1. Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. tslee@snubh.org
- Publication Type:Original Article
- Keywords:
Mesenteric artery;
Mesenteric vein;
Thrombosis;
Embolism;
Atherosclerosis
- MeSH:
Atherosclerosis;
Early Diagnosis;
Embolism;
Humans;
Incidence;
Ischemia;
Male;
Mesenteric Arteries;
Mesenteric Artery, Superior;
Mesenteric Veins;
Prognosis;
Recurrence;
Retrospective Studies;
Stents;
Thrombectomy;
Thrombosis;
Treatment Failure;
Vascular Diseases;
Venous Thrombosis
- From:Journal of the Korean Society for Vascular Surgery
2010;26(3):162-168
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Mesenteric vascular disease is a rare group of diseases including dissection, embolism, atherosclerosis, and venous thrombosis. Technical advances have led to increased diagnostic rates and new treatments with improved outcomes. The purpose of this study was to analyze the characteristics, methods of diagnosis, treatments, and outcomes of patients with mesenteric vascular diseases at our institution. METHODS: Between November 2003 and April 2010, 30 patients with mesenteric vascular disease diagnosed and treated at Seoul National University Bundang Hospital were reviewed retrospectively. Demographic data, etiology, treatment modality, and outcomes, including complications and mortalities, were analyzed. RESULTS: The mean age of the patients was 63.2 years (range, 43~91 years) and there was a male predominance (21 males vs. 9 females). The etiologies were superior mesenteric artery (SMA) dissection (n=13), SMA embolism (n=8), SMA atherosclerosis (n=5), and superior mesenteric vein thrombosis (n=4). Eleven patients underwent surgical treatment, while 11 patients underwent endovascular intervention and ten patients underwent conservative therapy with or without medication. No recurrence of symptoms or thrombosis was observed, except for one case of surgical thrombectomy, which underwent an endovascular aspiration thrombectomy with thrombolysis 9 days after the surgery. Two cases of technical endovascular treatment failure occurred, and one case of mortality after an endovascular stent insertion was observed. CONCLUSION: The incidence of mesenteric vascular diseases is increasing, and clinical manifestations and prognosis may vary from minor to life-threatening conditions. Early diagnosis is very important and the appropriate choice between endovascular intervention and a surgical approach may lead to good treatment results.
